|

Pembrolizumab & Enfortumab Vedotin (PEV) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: PADCEV

Pipeline

Phase 2: 1

Top Sponsors

  • University of Oklahoma1

Indications

  • Urothelial Carcinoma1
  • Cancer1

Oklahoma City, Oklahoma1 trial

Circulating Tumor DNA Response In Urothelial Cancer

OU Health Stephenson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.